Johnson & Johnson posts strong 2nd-quarter results and raises guidance for the full fiscal year. Philip Morris has a mixed 2nd-quarter and gets questions about its recent acquisition. Sarah Gentry and Connor Allen analyze those stories, pick out highlights from Netflix’s most recent results, and share why Blue Bird Corp. and DermTech are on their watchlists.
Looking for even more stocks to put on your watchlist? Get 50% off our Stock Advisor service by going to http://StockIdeas.fool.com.
The One Perspective To Never Forget
Introducing the new Motley Fool Money
‘Twas The Night Before The Night Before Christmas
Oracle’s Big Deal, Spider-Man’s Big Box Office
“They’re in a league of their own.”
Overreacting To Retail Data
1 Transatlantic Deal, 2 Reactions
Avoiding Seller’s Remorse
2 Stocks for the Great Outdoors
Intel’s Bet, Buzzfeed’s Debut
1 Question Investors Need To Answer
2 Stocks Too Cheap To Ignore
Salesforce Has a Co-CEO…Again
Would Meta Platforms Buy Roblox?
Jack Dorsey Exits Twitter
“It’s the mud that makes us.”
Best Buy, Dick’s Sporting Goods, Zoom Video
Is a Monster Merger Brewing?
Big Retail Earnings, Packers For Sale
Holiday Spending Preview
Create your
podcast in
minutes
It is Free
Motley Fool Money
Rule Breaker Investing
Industry Focus
Motley Fool Answers